Metabolic syndrome and associated factors in patients with psoriatic arthritis.

Abstract

In Ukraine, the prevalence of psoriasis is estimated to be around 2–3% of the population, which aligns with global trends. Given that Ukraine has a population of approximately 40 million people, this suggests that about 1.2 million people in Ukraine are affected by psoriasis. Psoriatic arthritis (PsA) affects between 13.5% and 47% of individuals with psoriasis. PsA can lead to significant issues, such as temporary or permanent disability and a decline in both physical and psychological well-being. In older patients, additional health complications, such as comorbidities and metabolic conditions like hyperuricemia, may complicate treatment and necessitate a more thorough differential diagnosis. The aim of the study. The goal of our study was to assess the role of metabolic syndrome in the progression of PsA and identify the association with hyperuricemia.